- Release Date: 19/04/24 08:36
- Summary: Type D Response Submitted and Received by the US FDA
- Price Sensitive: Yes
- Download Document 157.42KB
- Forums
- ASX - By Stock
- PAR
- Ann: Type D Response Submitted and Received by the US FDA
Ann: Type D Response Submitted and Received by the US FDA
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M |
Open | High | Low | Value | Volume |
20.0¢ | 20.3¢ | 18.5¢ | $754.5K | 3.889M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 361757 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 408912 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 430162 | 0.190 |
11 | 287710 | 0.185 |
14 | 101672 | 0.180 |
4 | 48369 | 0.175 |
5 | 85938 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 408912 | 6 |
0.210 | 21538 | 2 |
0.220 | 59400 | 3 |
0.225 | 18604 | 1 |
0.230 | 45000 | 1 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online